HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wenyue Hu Selected Research

N- ((5- (3- (4,6- difluoro- 1H- benzimidazol- 2- yl)- 1H- indazol- 5- yl)- 4- methylpyridin- 3- yl)methyl)ethanamine

10/2016Spectrum and Degree of CDK Drug Interactions Predicts Clinical Performance.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Wenyue Hu Research Topics

Disease

7Neoplasms (Cancer)
01/2020 - 11/2011
5Neutropenia
11/2020 - 01/2015
3Breast Neoplasms (Breast Cancer)
01/2020 - 04/2016
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 03/2015
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2021 - 01/2020
2Leukemia
01/2021 - 01/2020
2Genomic Instability
01/2015 - 07/2011
2Cardiotoxicity
12/2012 - 09/2012
2Prostatic Neoplasms (Prostate Cancer)
07/2012 - 11/2011
1Virus Diseases (Viral Diseases)
11/2021
1Infections
11/2021
1Inflammation (Inflammations)
11/2021
1Guillain-Barre Syndrome
10/2021
1Diarrhea
01/2019
1Lung Neoplasms (Lung Cancer)
07/2015
1Brain Neoplasms (Brain Tumor)
07/2015
1Glioblastoma (Glioblastoma Multiforme)
03/2015
1Body Weight (Weight, Body)
01/2015
1Cardiomegaly (Heart Hypertrophy)
11/2013
1Melanoma (Melanoma, Malignant)
10/2012
1Hyperplasia
10/2012
1Flushing
10/2012
1Cardiomyopathies (Cardiomyopathy)
09/2012
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
09/2012
1Heart Failure
09/2012
1Hepatocellular Carcinoma (Hepatoma)
01/2005

Drug/Important Bio-Agent (IBA)

5Pharmaceutical PreparationsIBA
11/2020 - 07/2012
5palbociclibIBA
01/2020 - 04/2016
3lorlatinibIBA
01/2021 - 03/2015
3Phosphotransferases (Kinase)IBA
03/2015 - 09/2012
2Anaplastic Lymphoma KinaseIBA
01/2021 - 07/2015
2Cyclin-Dependent Kinases (cdk Proteins)IBA
01/2020 - 04/2016
2ribociclibIBA
01/2019 - 10/2016
2abemaciclibIBA
01/2019 - 10/2016
1Polysaccharides (Glycans)IBA
11/2021
1Histones (Histone)IBA
11/2021
1AntigensIBA
01/2021
1Immunoconjugates (Immunoconjugate)IBA
01/2021
1GemcitabineFDA Link
11/2020
1pegfilgrastim (Neulasta)FDA Link
11/2020
1Filgrastim (Neupogen)FDA Link
11/2020
1Antineoplastic Agents (Antineoplastics)IBA
11/2020
1Doxorubicin (Adriamycin)FDA LinkGeneric
11/2020
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
11/2020
1Carboplatin (JM8)FDA LinkGeneric
11/2020
1Paclitaxel (Taxol)FDA LinkGeneric
11/2020
1Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
01/2020
1fms-Like Tyrosine Kinase 3IBA
01/2020
1Cyclin-Dependent Kinase 4IBA
01/2019
1dinaciclibIBA
10/2016
1N- ((5- (3- (4,6- difluoro- 1H- benzimidazol- 2- yl)- 1H- indazol- 5- yl)- 4- methylpyridin- 3- yl)methyl)ethanamineIBA
10/2016
1Adenosine Triphosphate (ATP)IBA
10/2016
1Estrogen Receptor Modulators (Antiestrogen)IBA
04/2016
1CrizotinibIBA
03/2015
1Biomarkers (Surrogate Marker)IBA
01/2015
1bosutinibIBA
11/2013
1PF-04254644IBA
12/2012
1CalciumIBA
12/2012
1Adenosine Monophosphate (AMP)IBA
12/2012
1MitogensIBA
10/2012
1Proteins (Proteins, Gene)FDA Link
10/2012
1PF-04880594IBA
10/2012
1CytokinesIBA
10/2012
1Interleukin-8 (Interleukin 8)IBA
10/2012
1mirdametinibIBA
10/2012
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
10/2012
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
10/2012
1bafilomycin AIBA
09/2012
1bcr-abl Fusion ProteinsIBA
09/2012
1Imatinib Mesylate (Gleevec)FDA Link
09/2012
1Androgen Receptors (Androgen Receptor)IBA
07/2012
1Checkpoint Kinase 1IBA
07/2011
1perfluorooctane sulfonic acidIBA
01/2005

Therapy/Procedure

4Therapeutics
10/2021 - 09/2012
2Drug Therapy (Chemotherapy)
11/2020 - 01/2020
2Oral Administration
01/2019 - 11/2011
1Castration
11/2011